rabeprazole has been researched along with Hyponatremia in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"With the exception of lansoprazole, this study suggests an association between any newly initiated PPI-treatment and hospitalization due to hyponatremia." | 3.91 | Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. ( Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Falhammar, H | 1 |
Lindh, JD | 1 |
Calissendorff, J | 1 |
Skov, J | 1 |
Nathanson, D | 1 |
Mannheimer, B | 1 |
1 other study available for rabeprazole and Hyponatremia
Article | Year |
---|---|
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Esomeprazole; Female; Hospitalization; Humans; Hyponatre | 2019 |